✦ LIBER ✦

Neuropsychological performance during a double-blind, placebo-controlled trial of copolymer-1 in relapsing-remitting multiple sclerosis

✍ Scribed by M. Grossman; K. Onishi; H. Thompson; M. D'Esposito; C. Armstrong; J. Cohen

Book ID: 119109388
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 156 KB
Volume: 56-63
Category: Article
ISSN: 0165-5728
DOI: 10.1016/0165-5728(95)98973-f

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Firategrast for relapsing remitting mult

Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial

✍ David H Miller; Thomas Weber; Richard Grove; Claire Wardell; Joseph Horrigan; Ol 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 267 KB

Intravenous immunoglobulin treatment in

Intravenous immunoglobulin treatment in relapsing-remitting multiple sclerosis: A randomized, double-blind multicenter, placebo-controlled trial

✍ A. Achiron; R. Gilad; S. Hassin; Y. Barak; U. Gabbay; I. Ziv; Y. Goldhamer; E. M 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Randomised double-blind placebo-controll

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

✍ George C Ebers 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 97 KB

Randomized double-blinded placebo contro

Randomized double-blinded placebo controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24 months clinical and MRI results

✍ I. Millefiorim; C. Gasperini 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Magnetic resonance imaging results of th

Magnetic resonance imaging results of the PRISMS trial: A randomized, double-blind, placebo-controlled study of interferon-β1a in relapsing-remitting multiple sclerosis

✍ David K. B. Li; Donald W. Paty 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 2 views

The PRISMS (Prevention of Relapses and Disability by Interferon-␤1a Subcutaneously in Multiple Sclerosis) trial was a doubleblind, randomized, multicenter, phase III, placebo-controlled study of interferon-␤1a in 560 patients from 22 centers in 9 countries with clinically definite or laboratory-supp

Glatiramer acetate in combination with m

Glatiramer acetate in combination with minocycline in patients with relapsing--remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial

✍ Metz, L.; Li, D.; Traboulsee, A.; Myles, M.; Duquette, P.; Godin, J.; Constantin 📂 Article 📅 2009 🏛 SAGE Publications 🌐 English ⚖ 317 KB